首页|University of Milan Reports Findings in Personalized Medicine (Novel artificial intelligence for diabetic retinopathy and diabetic macular edema: what is new in 2024?)
University of Milan Reports Findings in Personalized Medicine (Novel artificial intelligence for diabetic retinopathy and diabetic macular edema: what is new in 2024?)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of a report. According to news reporting fr om Milan, Italy, by NewsRx journalists, research stated, “Given the increasing g lobal burden of diabetic retinopathy and the rapid advancements in artificial in telligence, this review aims to summarize the current state of artificial intell igence technology in diabetic retinopathy detection and management, assessing it s potential to improve care and visual outcomes in real-world settings. Most rec ent studies focused on the integration of artificial intelligence in the field o f diabetic retinopathy screening, focusing on real-world efficacy and clinical i mplementation of such artificial intelligence models.” The news correspondents obtained a quote from the research from the University o f Milan, “Additionally, artificial intelligence holds the potential to predict d iabetic retinopathy progression, enhance personalized treatment strategies, and identify systemic disease biomarkers from ocular images through ‘oculomics’, mov ing towards a more precise, efficient, and accessible care. The emergence of fou ndation model architectures and generative artificial intelligence, which more c learly reflect the clinical care process, may enable rapid advances in diabetic retinopathy care, research and medical education. This review explores the emerg ing technology of artificial intelligence to assess the potential to improve pat ient outcomes and optimize personalized management in healthcare delivery and me dical research.”
MilanItalyEuropeArtificial Intelli genceDiabetic AngiopathiesDiabetic RetinopathyDrugs and TherapiesEmergin g TechnologiesEye Diseases and ConditionsHealth and MedicineMachine Learni ngMacular DegenerationMacular EdemaNutritional and Metabolic Diseases and ConditionsOphthalmologyPersonalized MedicinePersonalized TherapyRetinal DegenerationRetinal Diseases and ConditionsRetinopathyTechnologyVascular Diseases and Conditions
NETL
NSTL
